|
1
|
Selvakumaran M, Pisarcik DA, Bao R, Yeung
AT and Hamilton TC: Enhanced cisplatin cytotoxicity by disturbing
the nucleotide excision repair pathway in ovarian cancer cell
lines. Cancer Res. 63:11–16. 2003.PubMed/NCBI
|
|
2
|
Yang X, Xing H, Gao Q, Chen G, Lu Y, Wang
S and Ma D: Regulation of HtrA2/Omi by X-linked inhibitor of
apoptosis protein in chemoresistance in human ovarian cancer cells.
Gynecol Oncol. 97:413–421. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Lee S, Choi EJ, Jin C and Kim DH:
Activation of PI3K/Akt pathway by PTEN reduction and PIK3CA
mRNA amplification contributes to cisplatin resistance in an
ovarian cancer cell line. Gynecol Oncol. 97:26–34. 2005.PubMed/NCBI
|
|
4
|
Gifford G, Paul J, Vasey PA, Kaye SB and
Brown R: The acquisition of hMLH1 methylation in plasma DNA
after chemotherapy predicts poor survival for ovarian cancer
patients. Clin Cancer Res. 10:4420–4426. 2004.
|
|
5
|
Williams J, Lucas PC, Griffith KA, et al:
Expression of Bcl-xL in ovarian carcinoma is associated with
chemoresistance and recurrent disease. Gynecol Oncol. 96:287–295.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Roninson IB: Tumor cell senescence in
cancer treatment. Cancer Res. 63:2705–2715. 2003.PubMed/NCBI
|
|
7
|
Elmore LW, Xu Di, Dumur C, Holt SE and
Gewirtz DA: Evasion of a single-step, chemotherapy-induced
senescence in breast cancer cells: implications for treatment
response. Clin Cancer Res. 11:2637–2643. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lee BY, Han JA, Im JS, et al:
Senescence-associated β-galactosidase is lysosomal β-galactosidase.
Aging Cell. 5:187–195. 2006.
|
|
9
|
Bartkova J, Rezaei N, Liontos M, et al:
Oncogene-induced senescence is part of the tumorigenesis barrier
imposed by DNA damage checkpoints. Nature. 444:633–637. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
te Poele RH, Okorokov AL, Jardine L,
Cummings J and Joel SP: DNA damage is able to induce senescence in
tumor cells in vitro and in vivo. Cancer Res. 62:1876–1883.
2002.PubMed/NCBI
|
|
11
|
Schmitt CA, Fridman JS, Yang M, et al: A
senescence program controlled by p53 and p16INK4a
contributes to the outcome of cancer therapy. Cell. 109:335–346.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Roninson IB: Tumour senescence as a
determinant of drug response in vivo. Drug Resist Updat. 5:204–208.
2002. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Fang K, Chiu CC, Li CH, Chang YT and Hwang
HT: Cisplatin-induced senescence and growth inhibition in human
non-small cell lung cancer cells with ectopic transfer of
p16INK4a. Oncol Res. 16:479–488. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Lee AS: The glucose-regulated proteins:
stress induction and clinical applications. Trends Biochem Sci.
26:504–510. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Ranganathan AC, Zhang L, Adam AP and
Aguirre-Ghiso JA: Functional coupling of p38-induced up-regulation
of BiP and activation of RNA-dependent protein kinase-like
endoplasmic reticulum kinase to drug resistance of dormant
carcinoma cells. Cancer Res. 66:1702–1711. 2006. View Article : Google Scholar
|
|
16
|
Fu Y, Li J and Lee AS: GRP78/BiP inhibits
endoplasmic reticulum BIK and protects human breast cancer cells
against estrogen-starvation induced apoptosis. Cancer Res.
67:3734–3740. 2007. View Article : Google Scholar
|
|
17
|
Reddy RK, Mao C, Baumeister P, Austin RC,
Kaufman RJ and Lee AS: Endoplasmic reticulum chaperone protein
GRP78 protects cells from apoptosis induced by topoisomerase
inhibitors: role of ATP binding site in suppression of caspase-7
activation. J Biol Chem. 278:20915–20924. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Ermakova SP, Kang BS, Choi BY, et al:
(−)-Epigallocatechin gallate overcomes resistance to
etoposide-induced cell death by targeting the molecular chaperone
glucose-regulated protein 78. Cancer Res. 66:9260–9269. 2006.
|
|
19
|
Davidson DJ, Haskell C, Majest S, et al:
Kringle 5 of human plasminogen induces apoptosis of endothelial and
tumour cells through surface-expressed glucose-regulated protein
78. Cancer Res. 65:4663–4672. 2005. View Article : Google Scholar
|
|
20
|
Mandic A, Hansson J, Linder S and Shoshan
MC: Cisplatin induces endoplasmic reticulum stress and
nucleus-independent apoptotic signaling. J Biol Chem.
278:9100–9106. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Lee HK, Xiang CL, Cazacu S, et al: GRP78
is overexpressed in glioblastomas and regulates glioma cell growth
and apoptosis. Neuro Oncol. 10:236–243. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Jiang CC, Mao ZG, Avery-Kiejda K, Wade M,
Hersey P and Zhang XD: Glucose-regulated protein 78 antagonizes
cisplatin and adriamycin in human melanoma cells. Carcinogenesis.
30:197–204. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Zu K, Bihani T, Lin A, Park YM, Mori K and
Ip C: Enhanced selenium effect on growth arrest by BiP/GRP78
knockdown in p53-null human prostate cancer cells. Oncogene.
25:546–554. 2006.PubMed/NCBI
|
|
24
|
Tate S, Hirai Y, Takeshima N and Hasumi K:
CA125 regression during neoadjuvant chemotherapy as an independent
prognostic factor for survival in patients with advanced ovarian
serous adenocarcinoma. Gynecol Oncol. 96:143–149. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Wang W, Wang S, Song X, et al: The
relationship between c-FLIP expression and human papillomavirus
E2 gene disruption in cervical carcinogenesis. Gynecol
Oncol. 105:571–577. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Hawkins LK, Johnson L, Bauzon M, et al:
Gene delivery from the E3 region of replicating human adenovirus:
evaluation of the 6.7 K/gp19 K region. Gene Ther. 8:1123–1131.
2001. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fernandez PM, Tabbara SO, Jacobs LK, et
al: Overexpression of the glucose-regulated stress gene GRP78 in
malignant but not benign human breast lesions. Breast Cancer Res
Treat. 59:15–26. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Koomägi R, Mattern J and Volm M:
Glucose-related protein (GRP78) and its relationship to the
drug-resistance proteins P170, GST-pi, LRP56 and angiogenesis in
non-small cell lung carcinomas. Anticancer Res. 19:4333–4336.
1999.PubMed/NCBI
|
|
29
|
Taylor DD, Gercel-Taylor C and Parker LP:
Patient-derived tumor-reactive antibodies as diagnostic markers for
ovarian cancer. Gynecol Oncol. 115:112–120. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Arap MA, Lahdenranta J, Mintz PJ, et al:
Cell surface expression of the stress response chaperone GRP78
enables tumor targeting by circulating ligands. Cancer Cell.
6:275–284. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Zhou H, Zhang Y, Fu Y, Chan L and Lee AS:
Novel mechanism of anti-apoptotic function of 78-kDa
glucose-regulated protein (GRP78): endocrine resistance factor in
breast cancer, through release of B-cell lymphoma 2 (BCL-2) from
BCL-2-interacting killer (BIK). J Biol Chem. 286:25687–25696. 2011.
View Article : Google Scholar
|
|
32
|
Petroulakis E, Parsyan A, Dowling RJ, et
al: p53-dependent translational control of senescence and
transformation via 4E-BPs. Cancer Cell. 16:439–446. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Gannon HS, Donehower LA, Lyle S and Jones
SN: Mdm2-p53 signaling regulates epidermal stem cell senescence and
premature aging phenotypes in mouse skin. Dev Biol. 353:1–9. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Vaziri H, West MD, Allsopp RC, et al:
ATM-dependent telomere loss in aging human diploid fibroblasts and
DNA damage lead to the post-translational activation of p53 protein
involving poly(ADP-ribose) polymerase. EMBO J. 16:6018–6033. 1997.
View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Abbas T and Dutta A: p21 in cancer:
intricate networks and multiple activities. Nat Rev Cancer.
9:400–414. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Shen H and Maki CG: Persistent p21
expression after Nutlin-3a removal is associated with
senescence-like arrest in 4N cells. J Biol Chem. 285:23105–23114.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Roberson RS, Kussick SJ, Vallieres E, Chen
SY and Wu DY: Escape from therapy-induced accelerated cellular
senescence in p53-null lung cancer cells and in human lung cancers.
Cancer Res. 65:2795–2803. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Giorgi C, Ito K, Lin HK, et al: PML
regulates apoptosis at endoplasmic reticulum by modulating calcium
release. Science. 330:1247–1251. 2010. View Article : Google Scholar : PubMed/NCBI
|
